Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers
Clinical trial NCT01091220 · COMPLETED
Trial details
- NCT number
- NCT01091220
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.